title: The next generation: strong, specialized.
abstract: The first generation of RA biologics was good, but just the start. A new group of therapies - some novel, some familiar, but all powerful and each with a niche - will energize this market.
authors.forename: John
authors.initials: J
authors.lastname: Carroll